Does risperidone long acting injectable depot (RLAI) reduce number of admissions to hospital

Permalink: http://skupnikatalog.nsk.hr/Record/nsk.NSK01001006211/Details
Matična publikacija: Psychiatria Danubina. Supplement
29 (2017), 3 ; str. 652-655
Glavni autori: Najim, Hellme (Author), Pathak, Ashish, Pathak, Andrea
Vrsta građe: Članak
Jezik: eng
Predmet:
LEADER 01018naa a2200289 i 4500
001 NSK01001006211
003 HR-ZaNSK
005 20180906112926.0
007 ta
008 180906s2017 ci | |1|| ||eng
035 |a (HR-ZaNSK)001006211 
040 |a HR-ZaNSK  |b hrv  |c HR-ZaNSK  |e ppiak 
042 |a croatica 
044 |a ci  |c hr 
080 1 |a 615  |2 2011 
100 1 |a Najim, Hellme  |4 aut 
245 1 0 |a Does risperidone long acting injectable depot (RLAI) reduce number of admissions to hospital /  |c Hellme Najim, Ashish Pathak, Andrea Pathak. 
300 |b Ilustr. 
500 |a 6th Cambridge International Conference on Mental Health, Cambridge, 22-22nd September 2017 
504 |a Bibliografija: 16 jed. 
653 0 |a Risperidon  |a Liječenje  |a Shizofrenija  |a Hospitalizacija 
653 5 |a Engleska 
700 1 |a Pathak, Ashish  |4 aut 
700 1 |a Pathak, Andrea  |4 aut 
773 0 |t Psychiatria Danubina. Supplement  |x 1332-1366  |g 29 (2017), 3 ; str. 652-655  |w nsk.(HR-ZaNSK)000009867 
981 |b B01/17 
998 |b mamo1809